Objective The objective of this work was to investigate survival, dementia, and genotype‐phenotype
correlations in patients with Parkinson's disease (PD) with and without mutations on …

BACKGROUND AND PURPOSE: Quantitative evaluation of midbrain atrophy may be useful
in differentiating progressive supranulear palsy (PSP) from Parkinson disease (PD); …

Background Swallowing disturbances are an important issue in Parkinson's disease (PD)
as several studies have shown that they are associated with increased risk of aspiration …

We assessed the effect of 3‐month treatment of sertraline (50 mg) or low‐dose amitriptyline (25
mg) on depression and quality of life in 31 patients with Parkinson's disease in a …

We analysed the Leucine-Rich Repeat Kinase 2 (LRRK2) gene for the G2019S mutation in
1245 consecutive, unrelated patients with primary degenerative parkinsonism, and collected …

Background The rates of cognitive decline in patients with Parkinson's disease (PD) are
higher than in the general population. Age and disease duration have been associated with …

Objective Dopamine dysregulation syndrome (DDS) refers to a compulsive pattern of
dopaminergic drug misuse complicating Parkinson's disease (PD). To date, few data are available …

Background A very limited number of studies report data on the clinical features of Parkinson's
disease (PD) 20 years after onset and beyond. Objective To characterise PD 20 years …

A variety of cellular processes, including vesicle clustering in the presynaptic compartment,
are impaired in Parkinson’s disease and have been closely associated with α-synuclein …

This study investigated cognitive functions in Parkinson's disease (PD) patients with impulse
control disorders (ICDs) and aimed to identify possible predictors of behavioral outcome. In …